Showing results (131-140 of 427) with videos related to

Sort By:
Pageof 43
Expert Opinion on Emerging Drugs|May 31, 2023
Systemic mastocytosis: 2023 update on diagnosis and management in adultsAlessandro Costa, Emilia Scalzulli, Ida Carmosino, et al.
European Journal of Clinical Investigation|November 12, 2020
Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosisAlessandra Serrao, Manuela Merli, Benedetta Lucani, et al.
Leukemia Research|August 11, 2007
Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinibMassimo Breccia, Laura Cannella, Daniela Diverio, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2025
SOHO State of the Art Updates and Next Questions | Choosing the Best Frontline BCR::ABL1 Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia-How to Define the Treatment Value?Fadi G Haddad, Elias Jabbour, Massimo Breccia, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2008
Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib doseMassimo Breccia, Daniela Cilloni, Laura Cannella, et al.
Hematological Oncology|September 4, 2009
Cytogenetic and molecular responses in chronic phase chronic myeloid leukaemia patients receiving low dose of imatinib for intolerance to standard doseMassimo Breccia, Laura Cannella, Caterina Stefanizzi, et al.
Leukemia Research|June 18, 2011
5'-Azacitidine for therapy-related myelodysplastic syndromes after non-Hodgkin lymphoma treatmentMassimo Breccia, Adriano Salaroli, Giuseppina Loglisci, et al.
Frontiers in Oncology|June 23, 2023
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combinationChiara Masucci, Mauro Passucci, Emilia Scalzulli, et al.
Leukemia Research|September 11, 2007
Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphomaMassimo Breccia, Maurizio Martelli, Laura Cannella, et al.
Clinical Advances in Hematology & Oncology : H&O|December 19, 2019
Treatment-free remission in chronic myeloid leukemiaMatteo Molica, Kiran Naqvi, Jorge E Cortes, et al.
Pageof 43